-+ 0.00%
-+ 0.00%
-+ 0.00%

Gyre Therapeutics Affirms FY2026 Sales Guidance of $100.500M-$111.000M vs $109.500M Est

Benzinga·11/05/2026 22:30:51
Listen to the news
Gyre Therapeutics (NASDAQ:GYRE) affirms FY2026 sales outlook from $100.500 million-$111.000 million to $100.500 million-$111.000 million vs $109.500 million estimate.